a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases
Industry MedicalSpecialties
A.I.dvisor tells us that XGN and ESTA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XGN and ESTA's prices will move in lockstep.
Ticker / NAME | Correlation To XGN | 1D Price Change % | ||
---|---|---|---|---|
XGN | 100% | -1.43% | ||
ESTA - XGN | 27% Poorly correlated | -7.22% | ||
MASS - XGN | 23% Poorly correlated | -19.86% | ||
TRXO - XGN | 23% Poorly correlated | N/A | ||
MDXH - XGN | 22% Poorly correlated | -5.76% | ||
ICUI - XGN | 21% Poorly correlated | -1.80% | ||
More |
Ticker / NAME | Correlation To XGN | 1D Price Change % |
---|---|---|
XGN | 100% | -1.43% |
Medical Specialties category (428 stocks) | 14% Poorly correlated | -1.28% |
Medical Specialties category (418 stocks) | 14% Poorly correlated | -1.48% |